tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Belite Bio, Inc. ADR (BLTE) Financial Statements

Compare
27 Followers

Belite Bio, Inc. ADR Financial Overview

Belite Bio, Inc. ADR's market cap is currently $1.77B. The company's EPS TTM is $-1.108; its P/E ratio is ―; Belite Bio, Inc. ADR is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -399.00K$ -198.00K$ -30.00K$ -17.00K
Operating Income$ -31.67M$ -12.82M$ -9.80M$ -5.74M
EBITDA$ -31.53M$ -12.43M$ -9.64M$ -5.71M
Net Income$ -31.63M$ -12.47M$ -9.79M$ -5.75M
Balance Sheet
Cash & Short-Term Investments$ 88.16M$ 42.09M$ 17.34M$ 25.62M
Total Assets$ 94.64M$ 44.27M$ 18.35M$ 25.74M
Total Debt$ 886.00K$ 866.00K$ 31.81M$ 31.81M
Net Debt$ -87.27M$ -41.22M$ 14.46M$ 6.19M
Total Liabilities$ 4.21M$ 2.77M$ 33.44M$ 32.78M
Stockholders' Equity$ 90.43M$ 41.50M$ -15.09M$ -7.04M
Cash Flow
Free Cash Flow$ -29.90M$ -11.85M$ -7.55M$ -4.46M
Operating Cash Flow$ -29.84M$ -11.46M$ -7.47M$ -4.44M
Investing Cash Flow$ -63.00K$ -394.00K$ -56.00K$ -20.00K
Financing Cash Flow$ 75.96M$ 36.96M$ -583.00K$ 28.06M
Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History

Belite Bio, Inc. ADR Debt to Assets

Belite Bio, Inc. ADR Cash Flow

Belite Bio, Inc. ADR Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis